While the tariff announcement on patented drugs sent Indian pharma stocks tumbling, a tentative digital trade deal could show a path forward.

Pfizer's deal with Trump was a relief to the pharma industry, signaling that drugmakers could strike similar agreements that would make them immune to tariffs.

While the tariff announcement on patented drugs sent Indian pharma stocks tumbling, a tentative digital trade deal could show a path forward.